A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)

NCT01050283 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Adenocarcinoma

Interventions

PROCEDURE: Comparator: [18F]-FDG PET/CT and Volumetric CT

Sponsor

Merck Sharp & Dohme LLC